Clinical trial
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis…
NCT00232271 · Melbourne Health, Other · Terminated
Key facts
| NCT number | NCT00232271 |
|---|---|
| Title | The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. |
| Official title | The Effect of Enoxaparin Sodium (Clexane) on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | Sanofi Industry National Heart Foundation, Australia |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | Clexane |
| Enrollment | 35 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Oct 4, 2005 |
| Last update posted | May 30, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: